# GPC3/Mesothelin-CAR-γδT Cells Against Cancers

> **NCT06196294** · PHASE1 · RECRUITING · sponsor: **Second Affiliated Hospital of Guangzhou Medical University** · enrollment: 30 (estimated)

## Conditions studied

- Pancreas Cancer
- Lung Cancer
- Liver Cancer
- Mesothelioma
- CAR-T Cell Therapy
- Solid Tumor, Adult

## Interventions

- **BIOLOGICAL:** Cell therapy for solid tumors

## Key facts

- **NCT ID:** NCT06196294
- **Lead sponsor:** Second Affiliated Hospital of Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-10
- **Primary completion:** 2030-11-30
- **Final completion:** 2036-12-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06196294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06196294, "GPC3/Mesothelin-CAR-γδT Cells Against Cancers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06196294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*